邓秋狄，博士，副教授，硕士研究生导师。主要聚焦于探索和验证血管新生性疾病（类风湿关节炎、肿瘤）有效的药物靶点，致力于发展和应用新颖的生物活性小分子物质。
联系邮箱：dengqiudi@gzhmu.edu.cn
研究方向：小分子生物化学、分子药理学（抗炎与免疫药物药理/中药抗炎与免疫药理、抗肿瘤药物药理/中药抗肿瘤药理）
招生专业（代码）：生物与医药（086000）
主要科研项目：
1. 国家自然科学基金委员会，青年科学基金项目，82104492，基于周细胞功能探究过山枫活性成分抗类风湿关节炎滑膜血管新生的作用，2022-01-01至2024-12-31，30万元，结题，主持。
2. 广州市科学技术局，基础与应用基础研究专题项目（优秀博士“续航”项目），2024A04J7996，周细胞ITGB1介导与成纤维样滑膜细胞的相互作用调控类风湿关节炎负荷的研究，2024-01-01至2025-12-31，10万元，结题，主持。
3. 广州市科学技术局，基础与应用基础研究项目（博士青年科技人员类），202102020017，AXL经由TGF-β1调控肿瘤相关巨噬细胞的极化促进非小细胞肺癌转移的作用研究，2021-04-01至2023-03-31，5万元，结题，主持。
4. 广东省中医药局，面上项目，20212126，过山枫活性成分扁蒴藤素靶向MAGL抑制类风湿关节炎滑膜血管新生的作用及机制研究，2021-01-01至2022-12-31，0万元，结题，主持。
5. 广州医科大学，科研能力提升项目（科研强基项目），肿瘤相关成纤维细胞来源的ITGA11介导NSCLC细胞铁死亡拮抗的作用与机制研究，2023-01-01至2024-12-31，15万元，结题，主持。
代表性论文（按时间倒序；#为第一作者，*为通讯作者）：
1. Su Haibo#*, Zhang Baoying#, Deng Qiudi#, Huang Jiaxin#, Feng Jinyu, Fu Yuan, Huang Yuejun, Deng Weikun, Su YingJun, Liu Huisheng, Shao Ning-Yi, Zhang Zhenhui*, Dai Jianwei*. Trained Immunity Exacerbates Inflammatory Arthritis Progression via Promoting Synovial Fibroblast Ferroptotic Resistance. Advanced Science, 2025, 12(46): e04245.
2. Li Zhan#; Huang Manting#; Wang Jiaying#; Lin Jinru; Wu Quanhui; Wang Pu; Zhuo Shanggui; Zhang Weisong; Liu Zhiling; Deng Qiudi*; Yu Xiyong*; Lei Xueping*. Betulin, an active component from Chinese herb birch bark, suppresses tumor angiogenesis and tumor growth by inhibiting the PAX2/VEGF-A/VEGR2 signaling pathway in non-small cell lung cancer. Phytomedicine, 2025, 148: 157445.
3. Lei Xueping#; Li Zhan#; Huang Manting#; Huang Lijuan#; Huang Yong; Lv Sha; Zhang Weisong; Chen Zhuowen; Ke Yuanyu; Li Songpei; Chen Jingfei; Yang Xiangyu; Deng Qiudi*; Liu Junshan*; Yu Xiyong*. Gli1-mediated tumor cell-derived bFGF promotes tumor angiogenesis and pericyte coverage in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research, 2024, 43(1): 83.
4. Lin Kaili#; Huang Lijuan#; Zhang Yu#; Chen Minshan; Li Zhan; Yung Ken Kin Lam; Lv Sha; Pan Qianrong; Zhang Weisong; Fu Jijun*; Li Wanshan*; Deng Qiudi*. The Antiangiogenic and Antitumor Effects of Scoparasin B in Non-Small-Cell Lung Cancer. Journal of Natural Products, 2023, 86(2): 368-379.
5. Lei Xueping#; Li Zhan#; Zhong Yihang#; Li Songpei; Chen Jiacong; Ke Yuanyu; Lv Sha; Huang Lijuan; Pan Qianrong; Zhao Lixin; Yang Xiangyu; Chen Zisheng*; Deng Qiudi*; Yu Xiyong*. Gli1 promotes epithelial–mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating Snail transcriptional activity and stability. Acta Pharmaceutica Sinica B, 2022, 12(10): 3877-3890.
6. Peng Qingsheng#; Li Huan#; Deng Qiudi#; Liang Lu; Wang Fei; Lin Yinshan; Yang Langyu; Zhang Yu*; Yu Xiyong*; Zhang Lingmin*. Hybrid artificial cell-mediated epigenetic inhibition in metastatic lung cancer. Journal of Colloid and Interface Science, 2021, 603: 319-332.
7. Deng Qiudi#; Lei Xueping#; Zhong Yihang; Chen Minshan; Ke Yuanyu; Li Zhan; Chen Jing; Huang Lijuan; Zhang Yu; Liang Lu; Lin Zhongxiao; Liu Qing*; Li Songpei*; Yu Xiyong*. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition. Acta Pharmacologica Sinica, 2021, 42(9): 1486-1497.
8. Lei Xueping#; Zhong Yihang#; Huang Lijuan; Li Songpei; Fu Jijun; Zhang Lingmin; Zhang Yu; Deng Qiudi*; Yu Xiyong*. Identification of a novel tumor angiogenesis inhibitor targeting Shh/Gli1 signaling pathway in Non-small cell lung cancer. Cell Death & Disease, 2020, 11(4): 232.
